Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhaled bronchodilator administration during mechanical ventilation.

Alexander G Duarte1

  • 1Division of Pulmonary and Critical Care Medicine, University of Texas Medical Branch, Galveston, TX 77555-0561, USA. aduarte@utmb.edu.

Respiratory Care
|May 29, 2004
PubMed
Summary

Administering inhaled bronchodilators to mechanically ventilated patients requires careful technique and device selection to maximize drug delivery to the lower airways. Optimizing this process improves treatment effectiveness for respiratory conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of Hospitalized and Critically Ill Adults with Murine Typhus, Galveston, Texas, USA, 2019-2023.

Emerging infectious diseases·2026
Same author

Inhaler Technique in Chronic Obstructive Pulmonary Disease: Patient Impairments and Bronchodilation.

Annals of the American Thoracic Society·2026
Same author

Aerosol Therapy in the Emergency Department.

Journal of aerosol medicine and pulmonary drug delivery·2026
Same author

Utilization of Pulmonary Rehabilitation Following Hospitalization for COVID-19.

Journal of cardiopulmonary rehabilitation and prevention·2023
Same author

Structured Evaluation and Management of Patients with COPD in an Accredited Program.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2023
Same author

Corticosteroids and Outcomes in Solid Organ Transplant Recipients Infected With Severe Acute Respiratory Syndrome Coronavirus 2.

Mayo Clinic proceedings. Innovations, quality & outcomes·2023

Area of Science:

  • Respiratory Medicine
  • Critical Care Medicine
  • Pharmacology

Background:

  • Inhaled bronchodilators are crucial for managing respiratory distress in mechanically ventilated patients.
  • Lower respiratory tract drug deposition is a challenge in mechanically ventilated individuals compared to nonintubated subjects.
  • Effective bronchodilator delivery is essential for relieving dyspnea and reversing bronchoconstriction.

Purpose of the Study:

  • To review and optimize the administration of inhaled bronchodilators in mechanically ventilated patients.
  • To identify strategies for enhancing lower respiratory tract drug deposition.
  • To guide the selection of appropriate aerosol-generating devices and administration techniques.

Main Methods:

  • Review of current literature on inhaled bronchodilator delivery in mechanical ventilation.

Related Experiment Videos

  • Analysis of factors influencing drug deposition, including device type, technique, and patient-ventilator interface.
  • Discussion of methods for assessing airway response, such as measuring airway resistance and intrinsic positive end-expiratory pressure.

    • Main Results:

    • Optimizing device selection, administration technique, dosing, and patient-ventilator interface can significantly increase lower respiratory tract deposition.
    • Assessment of airway resistance and intrinsic positive end-expiratory pressure aids in guiding bronchodilator dosing and timing.
    • Metered-dose inhalers and nebulizers can be administered safely and effectively with appropriate techniques.

    Conclusions:

    • Careful attention to administration technique and device selection is vital for effective inhaled bronchodilator therapy in mechanically ventilated patients.
    • Monitoring airway response can personalize and improve bronchodilator treatment strategies.
    • Optimized delivery enhances therapeutic outcomes for respiratory conditions in critical care settings.